Navigation Links
New hope for horse lovers as effective control for killer ragwort is proposed
Date:10/10/2007

Scientists propose developing an environmentally-friendly fungal spray that would specifically target Ragwort, infecting and killing the weed at a critical growth stage. This spray will contain a host-specific, plant pathogenic fungus as the active ingredient and will have no side-effects on non-target organisms and pose no threat to the environment. It would therefore provide a quick, safe and effective means for controlling Ragwort.

Ragwort is a common British weed which thrives on wasteland, road verges and railway land. The weed spreads easily to pasture land and is poisonous to horses, ponies, donkeys and other livestock, causing death through liver disease. It is estimated that over 6,500 horses are killed each year from Ragwort poisoning.

While current methods for controlling Ragwort, such as pulling, mowing and cutting, can be effective in the short term, they may actually promote future growth. Chemical herbicides can also be effective, but their lack of specificity means they tend to kill off surrounding vegetation and would be unsuitable on sites designated for nature conservation or as special scientific interest. Herbicides can also create spray drift hazards and leave residues in food commodities.

In order to start phase one of what could develop into a three phase project, CABI, a not-for-profit organisation, is looking to secure funds from a consortium of interested stakeholders. An anticipated budget of less than 20,000 would help fund the initial feasibility study, involving research into whether a suitably specific and damaging native fungus occurs on Ragwort and can be exploited to control the plant.

Phase 2 will involve finalising the fungal active ingredient, formulating it into a spray and conducing field trials. In phase 3, the spray will be registered and launched as a commercial product. CABI plans to set up this project as a market-driven venture and to re-invest any income generated b
'/>"/>

Contact: Lynsey Sterrey
l.sterrey@cabi.org
01-865-829-361
CABI
Source:Eurekalert

Page: 1 2

Related biology news :

1. Live vaccines more effective against horse herpes virus
2. Ancient DNA helps clarify the origins of two extinct New World horse species
3. Horse antibodies against the bird flu virus H5N1 are effective as treatment in mice
4. Horseshoe crab decline threatens shorebird species
5. Killing brain tumors from within: A Trojan horse approach
6. New evidence of early horse domestication
7. Trojan Horse agent halts bone metastasis in mice
8. Trojan horse strategy defeats drug-resistant bacteria
9. Horse genome assembled
10. Combination therapy boosts effectiveness of telomere-directed cancer cell death
11. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...rofessors recently received funding from the Natio...beneficial to understanding the environment. The t...ood, assistant professor in the Department of Biol... separate research projects. , His first project... and Functions from the Leaf to the Landscape," wi...
(Date:11/24/2009)...escribed by traditional healers in Brazil to treat...in to fever and flu. , Now for the first time, re...o scientifically prove the pain relieving properti...an mint. , Testing this ancient South American he...cha was able to show that when prepared as a ,tea,...
(Date:11/24/2009)...o understanding how sounds associated with Navy so...r if they hear it at all. , The same type of lar...to detect flaws in the space shuttle,s behemoth so...k inside the giant head of a whale. The scans are ... whale,s hearing anatomy using a breakthrough meth...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 1DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 2DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 3DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 4DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 5DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 6High cholesterol in midlife raises risk of late life dementia Kaiser Permanente study finds 53591 1High cholesterol in midlife raises risk of late life dementia Kaiser Permanente study finds 53591 2High cholesterol in midlife raises risk of late life dementia Kaiser Permanente study finds 53591 3Motorcyclist Lives On Rides On Through Organ Donation 53587 1Motorcyclist Lives On Rides On Through Organ Donation 53587 2Motorcyclist Lives On Rides On Through Organ Donation 53587 3Motorcyclist Lives On Rides On Through Organ Donation 53587 4Motorcyclist Lives On Rides On Through Organ Donation 53587 5
...ray-on films developed by UC San Diego chemists wi...ly reveal trace amounts of nitrogen-based explosiv...s on the films, which glow blue under ultraviolet ...fferent classes of explosive chemicals, a property..., or prevent one. , A recent episode of CSI: Miam...
...ing to a report from a CSIRO Wealth From Oceans Fl...ournal Geophysical Research Letters since 1950 Vi...n rainfall (March to May) compared to the average ...SIROs Dr Wenju Cai and Tim Cowan, say that the dec...s for about half of the total seasonal reduction.,...
... 25, 2008, approaching 5 p.m. PDT, NASA scientists...? , That,s because at that time the Phoenix Mars ... three legs to make a soft landing onto the northe... no valley is actually green on the Red Planet. Th... Mars Reconnaissance Orbiter,s HiRISE instrument. ...
Other Biology News:Glowing films developed by UC San Diego chemists reveal traces of explosives 2Understanding autumn rain decline in SE Australia 2Phoenix mission to Mars will search for climate clues 2Phoenix mission to Mars will search for climate clues 3
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... , SEATTLE, Nov. 24 Blue Marb...nd the Odessa Public Development Authority (OPDA) ...te,s Community Economic Revitalization Board (CERB... state,s first specialty biochemical biorefinery i...l significantly speed the development of our biore...
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-First...e global specialty biopharmaceutical company, toda...opean Medicines Agency for,velaglucerase alfa, the...nt,for the treatment of Type 1 Gaucher disease. Th...erase alfa that has been submitted, with previous,...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...BOLZANO, Italy, April 14 Health Robotics today an... 31, 2008, delivering record levels,of firm purcha...Revenues in FY2008 were EUR8.2 million, a 161% inc...d and enjoy the benefits of its indirect,sales-cha...ition, zero debt,financing, worldwide adoption of ...
... Virus-like Particle (VLP) Vaccine Candidate Based...ce and Ferrets Against the Spanish Flu and Highly ...ril 14 /PRNewswire-FirstCall/ -- Novavax, In...udy results showing that an investigational H1N1 v... Spanish influenza strain protected against both t...
...JOSEPH, Mich., April 14 GeneGo, Inc., the leading...at Professor Marcelo Bento Soares of Children,s Me...Stem Cell Partnership Program. The goal of the pr...maps for adult, embryonic, fetal, fibroblasts, hem...pluripotent and totipotent stem cells. , , "We fe...
Other Biology Technology:Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 2Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 3Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 4Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 5NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 2NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 3NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 4NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 5Children's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership Program 2
Hae III (High Concentration) from Takara Mirus Bio
2 ml SmartScan Racks from ABgene
Rabbit Anti-Leptin Receptor Polyclonal Antibody, Unconjugated from BioVision
...wer supply. Capable of producing up to 500 volts a...AGE, SDS-PAGE, DNA or RNA submarine gels as well a... is designed to operate in constant voltage or con...in either mode. The EC135-90 automatically crosses...
Biology Products: